ShockWave Medical shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $291 to $335.
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley has upgraded ShockWave Medical's stock from Equal-Weight to Overweight and raised its price target from $291 to $335. This has resulted in the shares of ShockWave Medical trading higher.
July 10, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ShockWave Medical's stock has been upgraded by Morgan Stanley, leading to a rise in its share price. The price target has been increased from $291 to $335.
The upgrade from Morgan Stanley is a positive signal for investors, indicating a bullish outlook for the stock. This has led to an increase in the share price. The raised price target also suggests that Morgan Stanley expects the stock to perform well in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100